Author = Razie Sabet
Design, synthesis, molecular docking of novel quinazolinone-azole derivatives as anticancer agents

Volume 11, Issue 2, June 2025

10.30476/tips.2025.105887.1285

Zahra Rezaei; Soghra Khabnadideh; Zeinab Faghih; Razieh Sabet; Leila Emami; Sara Sadeghian; Sedigheh Halimi


Assessment of Anti-tyrosinase and Antioxidant Activities along with Molecular Docking Studies, and in silico ADME of Some 3-Hydroxypyridin-4-one Derivatives

Volume 10, Issue 3, September 2024, Pages 251-258

10.30476/tips.2024.103318.1249

Fateme Zare; Sara Sadeghian; Mehdi Khoshneviszadeh; Mojgan Pasbani; Razieh Sabet; Hossein Sadeghpour


Synthesis of Deferiprone as a Widely Used Iron-Chelating Drug for the Treatment of Iron-Overload Diseases

Volume 10, Issue 1, March 2024, Pages 77-82

10.30476/tips.2024.102338.1236

Sara Sadeghian; Fateme Zare; Lotfollah Saghaie; Razieh Sabet


Evaluation of Antimicrobial Activity of Some Hybrids of Pyrimidine-Azole Derivatives along with Molecular docking study

Volume 9, Issue 3, September 2023, Pages 183-190

10.30476/tips.2023.98698.1195

Leila Emami; Fatemeh Zare; Kamiar Zomorodian; Mahshid Saber Nazar Agha; Razieh Sabet


Molecular Docking and Antimicrobial Evaluation of Some Novel Pyrano[2,3-C] Pyrazole Derivatives

Volume 6, Issue 2, June 2020, Pages 113-120

10.30476/tips.2020.86489.1051

Leila Emami; Leila Zamani; Razieh Sabet; Kamiar Zomorodian; Zahra Rezaei; Zeinab Faghih; Yeganeh Shahbazi; Soghra Khabnadideh